Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Softgel Capsules Market by Type (Gelatin Softgel Capsules, Non-Gelatin softgel Capsules), by Application (Pharmaceuticals, Health Supplements, Cosmetics), by Distribution Channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031

A16306

Pages: 265

Charts: 60

Tables: 151

Softgel Capsules Market Research, 2032

Softgel capsules are a specialized type of oral dosage form encapsulated in a soft gelatin shell, which holds liquid or semi-liquid content. These capsules are widely used in the pharmaceutical, nutraceutical, and cosmetics industries due to their ease of swallowing, better bioavailability, and ability to mask unpleasant tastes or odors.

Market Value Projections and Insights

  • The global softgel capsules market size was valued at $4.4 billion in 2021, and it is projected to reach $7.5 billion by 2031, growing at a CAGR of 5.4% from 2022 to 2031.
  • By type, the gelatin softgel capsules segment dominated the market share in 2021 and is anticipated to maintain its dominance over the forecast period.
  • By application, health supplements were the leading application segment in 2021 and are expected to drive softgel capsules market demand.
  • By distribution channel, pharmacies and drug stores held the largest share in the distribution channel in 2021, further contributing to the growth of the market.
  • Region-wise, North America generated the largest revenue share in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

 

The softgel capsules market is experiencing notable growth, driven by increased consumer preference for easy-to-swallow, fast-acting, and tasteless dosage forms. This trend is particularly prominent in the nutraceuticals sector, where supplements like fish oil and multivitamins are often encapsulated in softgels. Additionally, rising demand for enhanced bioavailability of drugs is pushing pharmaceutical companies to adopt softgel formulations, as they allow better absorption of poorly soluble drugs.

However, the softgel capsules market faces challenges such as high production costs and regulatory scrutiny around gelatin sourcing, especially with the growing demand for plant-based alternatives. For example, vegetarian and vegan consumers are increasingly seeking non-gelatin capsules made from materials like tapioca starch, which presents both a challenge and an opportunity for manufacturers.

The softgel capsules market opportunities lie in expanding the use of softgels in over-the-counter (OTC) medications, and the development of innovative, plant-based softgel capsules to cater to shifting consumer preferences. Companies like Catalent and Capsugel are key players in driving innovation in this space.

[TYPEGRAPH]

Industry Highlights

  • The demand for softgel capsules in the pharmaceutical sector is primarily driven by their ability to enhance the solubility and bioavailability of poorly soluble drugs.
  • The rising health consciousness among consumers is driving the demand for softgel-based dietary supplements, including vitamins, minerals, and omega-3 supplements.
  • The cosmetics industry is also utilizing softgel capsules for delivering skin care formulations.
  • Pharmacies and drug stores have emerged as the dominant distribution channel, offering easy access to softgel capsules.
  • North America remains the leading regional softgel capsules market due to its advanced healthcare infrastructure and high consumer demand for dietary supplements.

Softgel capsules have long been valued for their convenience, effectiveness, and enhanced bioavailability, making them a preferred choice for both consumers and manufacturers. Some softgel products can be highly valuable in the market, particularly those offering premium formulations, unique delivery systems, or specialized health benefits. These capsules can command high demand due to their effectiveness and ease of use, making them a sought-after option in pharmaceutical and supplement industries. Softgel capsules that mark important innovations or milestones in drug delivery technology, such as the introduction of non-gelatin variants, are especially prized by consumers and manufacturers alike. Many people associate softgel capsules with improved wellness experiences, recalling their smooth consumption and better absorption, which fosters trust and loyalty toward this dosage form.

[APPLICATIONGRAPH]

Key Areas Covered in the Report

  • Softgel capsules are widely recognized for their ease of consumption, bioavailability, and enhanced stability of active ingredients.
  • The softgel capsules market faces competition from other drug delivery formats, such as tablets, liquid suspensions, and chewable forms.
  • The rise of non-gelatin softgel capsules has brought diversity and innovation, catering to the growing demand for plant-based or vegetarian alternatives.
  • Health supplements and pharmaceutical applications continue to drive the popularity of softgel capsules, contributing to their enduring softgel capsules market presence.

Softgel capsules are in competition with alternative drug delivery formats such as tablets, chewable gummies, liquid suspensions, and other advanced delivery systems. As consumer demand for health supplements and pharmaceuticals increases, so does the demand for innovative, convenient formats that offer improved efficacy and user experience. The rise of plant-based and vegan lifestyles has spurred growth in the development of non-gelatin softgel capsules, providing an alternative to traditional gelatin-based capsules and addressing a key consumer need. This trend reflects a larger shift toward more natural, sustainable, and ethical products across the health and wellness industry.

Pharmaceutical companies are investing heavily in advanced formulations using softgel capsules to improve drug absorption and stability, further driving demand. Health supplements in softgel form, especially those containing essential vitamins, omega-3, and CBD oil, are gaining popularity due to their ease of ingestion and faster absorption, giving them an edge over other formats. Additionally, as consumers increasingly prioritize self-care and preventative health, the softgel capsules market for softgel health supplements continues to grow.

The rising demand for online health product platforms and pharmacies is giving consumers more access to softgel capsules, helping to accelerate their adoption. Pharmacies and drug stores, both physical and online, play a significant role in the distribution of softgel products, offering a variety of formulations to meet consumer needs across the pharmaceutical and health supplement sectors. As the softgel capsules market continues to evolve, innovations in softgel technology and formulations are expected to offer new opportunities for both pharmaceutical and nutraceutical applications.

[DISTRIBUTIONCHANNELGRAPH]

Topics discussed in the report

  • Analysis of softgel capsules market trends, drivers, and opportunities across key segments.
  • Competitive landscape and strategic initiatives of key market players.
  • Regional analysis highlighting the dominance of North America in the global market.
  • Insights into the role of non-gelatin softgels in the future of the industry.
  • Growth prospects for health supplements as a key application area for softgel capsules.

Segment Overview

The softgel capsules market is segmented into type, application, distribution channel, and region. By type, the market is categorized into gelatin softgel capsules and non-gelatin softgel capsules. On the basis of application, the market is segregated into pharmaceuticals, health supplements, and cosmetics. By distribution channel, the market is classified into supermarkets & hypermarkets, pharmacies & drug stores, and online providers. By region, the softgel capsules market is divided into North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and the Rest of LAMEA).

Gelatin softgel capsules held the largest softgel capsules market share in 2021 due to their versatility and cost-effectiveness. However, the rising popularity of plant-based alternatives is driving the growth of non-gelatin capsules. In addition, The health supplements segment accounted for the largest share in 2021, driven by the growing demand for dietary supplements across the globe. Further, Pharmacies and drug stores dominated the distribution channel in 2021, attributed to the convenience and trust associated with these outlets for consumers purchasing health-related products.

Comparative Matrix of Key Segments

Parameters

Gelatin Capsule

Non-Gelatin Capsules

Market Share

Largest share due to traditional applications in various nutritional as well as pharmaceutical purpose and availability of gelatin softgel capsule in the market by various key players.

Growing rapidly with digital platforms

Distribution Channels

Pharmacies, health stores, supermarkets

Online platforms, specialty health stores

Challenges

Concerns over animal origin, competition from alternatives

Higher production costs, limited availability

Key Players

Catalent, Aenova Group, Procaps Group

Captek Softgel International, Robinson Pharma

Regional Dynamics and Competition

The softgel capsules market is experiencing significant growth across various regions due to the increasing consumer demand for nutraceuticals, pharmaceuticals, and dietary supplements. North America holds a dominant position in the market, driven by high consumer awareness of health and wellness products, alongside a strong presence of key pharmaceutical manufacturers. The U.S., in particular, is a major contributor due to the aging population and rising demand for supplements aimed at preventing chronic diseases.

In Europe, stringent regulations around drug formulations have prompted the development of high-quality softgel capsules, especially in countries like Germany and the U.K. Furthermore, the Asia-Pacific region presents lucrative opportunities, with countries like India, China, and Japan leading the charge. The growing population, rising healthcare awareness, and increasing disposable income in these nations are contributing to the regional demand. Additionally, advancements in capsule manufacturing technologies and the expansion of contract manufacturing organizations (CMOs) in these regions are further driving softgel capsules market growth.

Emerging economies in Latin America and the Middle East also show promising potential, fueled by the increasing penetration of pharmaceutical products and the expansion of healthcare infrastructure. Overall, the global trend indicates a robust demand for softgel capsules, particularly in health-conscious markets.

[REGIONGRAPH]

Some of the major players analyzed in this report are Aenova Group, Best Formulations, Inc., Captek Softgel International, Inc., Catalant, Inc., DCC Plc. (Eurocaps), Procaps Groups, Robinson Pharma, Inc., Lyfe Group (Caps Canada), Sirio Pharma Co. (Ayanda), and Thermofisher Scientific, Inc. (Patheon).

Softgel Capsules Market News Release

  • In January 2022, Procaps Group (PROC) acquired the 1st U.S.-based softgel production facility and pharmaceutical R&D center.
  • In October 2021, Aenova Group, a global contract manufacturer and developer for the pharmaceutical and healthcare industries, developed probiotic softgel capsules, designed to support wellbeing through the gut flora. The capsules, which contain living bacteria or yeasts, are designed to combine the advantages of the soft gelatin formulation technology with the health benefits of probiotics.
  • In August 2021, Catalent, Inc. announced the acquisition of Bettera Holdings, LLC, a prominent manufacturer in the nutritional supplements market, which strengthened catalant’s softgel product portfolio and broadened manufacturing capabilities.
  • In February 2021, Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the launch of its CosmoPod Duo softgel capsule technology for the delivery of topical skin treatments.
  • In November 2020, Aenova Group launched new chewable VegaGels with algae-based omega-3 in multiple colors and flavors.
  • In October 2020, Catalent, Inc, expanded its manufacturing capacity of gelatin capsule by investing US$ 93 million in its capsules and health ingredients (CHI) division. The investment led the catalant to expand its overall production capacity of capsules within CHI's Capsugel portfolio by manufacturing 30 billion capsules annually. 
  • In October 2020, Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the launch of OptiGel DR technology for the formulation and manufacture of delayed/enteric release softgels.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the softgel capsules market segments, current trends, estimations, and dynamics of the softgel capsules market analysis from 2021 to 2031 to identify the prevailing softgel capsules market opportunities.
  • The softgel capsules market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the softgel capsules market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global softgel capsules market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Type
    • Gelatin Softgel Capsules
    • Non-Gelatin softgel Capsules
      • Material
        • Starch
        • Cellulose
        • Pullulan
  • By Application
    • Pharmaceuticals
    • Health Supplements
    • Cosmetics
  • By Distribution Channel
    • Supermarkets and Hypermarkets
    • Pharmacies and Drug Stores
    • Online Providers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest Of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest Of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest Of LAMEA


Key Market Players

  • DCC Plc. (Eurocaps)
  • Captek Softgel International, Inc.
  • Lyfe Group (Caps Canada)
  • Robinson Pharma, Inc.
  • Sirio Pharma Co. (Ayanda)
  • Procaps Groups
  • Best Formulations, Inc.
  • Catalant, Inc.
  • Thermofisher Scientific, Inc (Patheon)
  • Aenova Group
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

    • 3.7.Patent Landscape

  • CHAPTER 4: SOFTGEL CAPSULES MARKET, BY TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Gelatin Softgel Capsules

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market share analysis by country

    • 4.3 Non-Gelatin softgel Capsules

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market share analysis by country

      • 4.3.4 Non-Gelatin softgel Capsules Softgel Capsules Market by Material

        • 4.3.4.1 Starch Market size and forecast, by region
        • 4.3.4.2 Cellulose Market size and forecast, by region
        • 4.3.4.3 Pullulan Market size and forecast, by region
  • CHAPTER 5: SOFTGEL CAPSULES MARKET, BY APPLICATION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Pharmaceuticals

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market share analysis by country

    • 5.3 Health Supplements

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market share analysis by country

    • 5.4 Cosmetics

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market share analysis by country

  • CHAPTER 6: SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Supermarkets and Hypermarkets

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market share analysis by country

    • 6.3 Pharmacies and Drug Stores

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market share analysis by country

    • 6.4 Online Providers

      • 6.4.1 Key market trends, growth factors and opportunities

      • 6.4.2 Market size and forecast, by region

      • 6.4.3 Market share analysis by country

  • CHAPTER 7: SOFTGEL CAPSULES MARKET, BY REGION

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 North America

      • 7.2.1 Key trends and opportunities

      • 7.2.2 North America Market size and forecast, by Type

        • 7.2.2.1 North America Non-Gelatin softgel Capsules Softgel Capsules Market by Material
      • 7.2.3 North America Market size and forecast, by Application

      • 7.2.4 North America Market size and forecast, by Distribution Channel

      • 7.2.5 North America Market size and forecast, by country

        • 7.2.5.1 U.S.
          • 7.2.5.1.1 Key market trends, growth factors and opportunities
          • 7.2.5.1.2 Market size and forecast, by Type
          • 7.2.5.1.3 Market size and forecast, by Application
          • 7.2.5.1.4 Market size and forecast, by Distribution Channel
        • 7.2.5.2 Canada
          • 7.2.5.2.1 Key market trends, growth factors and opportunities
          • 7.2.5.2.2 Market size and forecast, by Type
          • 7.2.5.2.3 Market size and forecast, by Application
          • 7.2.5.2.4 Market size and forecast, by Distribution Channel
        • 7.2.5.3 Mexico
          • 7.2.5.3.1 Key market trends, growth factors and opportunities
          • 7.2.5.3.2 Market size and forecast, by Type
          • 7.2.5.3.3 Market size and forecast, by Application
          • 7.2.5.3.4 Market size and forecast, by Distribution Channel
    • 7.3 Europe

      • 7.3.1 Key trends and opportunities

      • 7.3.2 Europe Market size and forecast, by Type

        • 7.3.2.1 Europe Non-Gelatin softgel Capsules Softgel Capsules Market by Material
      • 7.3.3 Europe Market size and forecast, by Application

      • 7.3.4 Europe Market size and forecast, by Distribution Channel

      • 7.3.5 Europe Market size and forecast, by country

        • 7.3.5.1 Germany
          • 7.3.5.1.1 Key market trends, growth factors and opportunities
          • 7.3.5.1.2 Market size and forecast, by Type
          • 7.3.5.1.3 Market size and forecast, by Application
          • 7.3.5.1.4 Market size and forecast, by Distribution Channel
        • 7.3.5.2 France
          • 7.3.5.2.1 Key market trends, growth factors and opportunities
          • 7.3.5.2.2 Market size and forecast, by Type
          • 7.3.5.2.3 Market size and forecast, by Application
          • 7.3.5.2.4 Market size and forecast, by Distribution Channel
        • 7.3.5.3 UK
          • 7.3.5.3.1 Key market trends, growth factors and opportunities
          • 7.3.5.3.2 Market size and forecast, by Type
          • 7.3.5.3.3 Market size and forecast, by Application
          • 7.3.5.3.4 Market size and forecast, by Distribution Channel
        • 7.3.5.4 Italy
          • 7.3.5.4.1 Key market trends, growth factors and opportunities
          • 7.3.5.4.2 Market size and forecast, by Type
          • 7.3.5.4.3 Market size and forecast, by Application
          • 7.3.5.4.4 Market size and forecast, by Distribution Channel
        • 7.3.5.5 Spain
          • 7.3.5.5.1 Key market trends, growth factors and opportunities
          • 7.3.5.5.2 Market size and forecast, by Type
          • 7.3.5.5.3 Market size and forecast, by Application
          • 7.3.5.5.4 Market size and forecast, by Distribution Channel
        • 7.3.5.6 Rest of Europe
          • 7.3.5.6.1 Key market trends, growth factors and opportunities
          • 7.3.5.6.2 Market size and forecast, by Type
          • 7.3.5.6.3 Market size and forecast, by Application
          • 7.3.5.6.4 Market size and forecast, by Distribution Channel
    • 7.4 Asia-Pacific

      • 7.4.1 Key trends and opportunities

      • 7.4.2 Asia-Pacific Market size and forecast, by Type

        • 7.4.2.1 Asia-Pacific Non-Gelatin softgel Capsules Softgel Capsules Market by Material
      • 7.4.3 Asia-Pacific Market size and forecast, by Application

      • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel

      • 7.4.5 Asia-Pacific Market size and forecast, by country

        • 7.4.5.1 Japan
          • 7.4.5.1.1 Key market trends, growth factors and opportunities
          • 7.4.5.1.2 Market size and forecast, by Type
          • 7.4.5.1.3 Market size and forecast, by Application
          • 7.4.5.1.4 Market size and forecast, by Distribution Channel
        • 7.4.5.2 China
          • 7.4.5.2.1 Key market trends, growth factors and opportunities
          • 7.4.5.2.2 Market size and forecast, by Type
          • 7.4.5.2.3 Market size and forecast, by Application
          • 7.4.5.2.4 Market size and forecast, by Distribution Channel
        • 7.4.5.3 India
          • 7.4.5.3.1 Key market trends, growth factors and opportunities
          • 7.4.5.3.2 Market size and forecast, by Type
          • 7.4.5.3.3 Market size and forecast, by Application
          • 7.4.5.3.4 Market size and forecast, by Distribution Channel
        • 7.4.5.4 Australia
          • 7.4.5.4.1 Key market trends, growth factors and opportunities
          • 7.4.5.4.2 Market size and forecast, by Type
          • 7.4.5.4.3 Market size and forecast, by Application
          • 7.4.5.4.4 Market size and forecast, by Distribution Channel
        • 7.4.5.5 South Korea
          • 7.4.5.5.1 Key market trends, growth factors and opportunities
          • 7.4.5.5.2 Market size and forecast, by Type
          • 7.4.5.5.3 Market size and forecast, by Application
          • 7.4.5.5.4 Market size and forecast, by Distribution Channel
        • 7.4.5.6 Rest of Asia-Pacific
          • 7.4.5.6.1 Key market trends, growth factors and opportunities
          • 7.4.5.6.2 Market size and forecast, by Type
          • 7.4.5.6.3 Market size and forecast, by Application
          • 7.4.5.6.4 Market size and forecast, by Distribution Channel
    • 7.5 LAMEA

      • 7.5.1 Key trends and opportunities

      • 7.5.2 LAMEA Market size and forecast, by Type

        • 7.5.2.1 LAMEA Non-Gelatin softgel Capsules Softgel Capsules Market by Material
      • 7.5.3 LAMEA Market size and forecast, by Application

      • 7.5.4 LAMEA Market size and forecast, by Distribution Channel

      • 7.5.5 LAMEA Market size and forecast, by country

        • 7.5.5.1 Brazil
          • 7.5.5.1.1 Key market trends, growth factors and opportunities
          • 7.5.5.1.2 Market size and forecast, by Type
          • 7.5.5.1.3 Market size and forecast, by Application
          • 7.5.5.1.4 Market size and forecast, by Distribution Channel
        • 7.5.5.2 Saudi Arabia
          • 7.5.5.2.1 Key market trends, growth factors and opportunities
          • 7.5.5.2.2 Market size and forecast, by Type
          • 7.5.5.2.3 Market size and forecast, by Application
          • 7.5.5.2.4 Market size and forecast, by Distribution Channel
        • 7.5.5.3 South Africa
          • 7.5.5.3.1 Key market trends, growth factors and opportunities
          • 7.5.5.3.2 Market size and forecast, by Type
          • 7.5.5.3.3 Market size and forecast, by Application
          • 7.5.5.3.4 Market size and forecast, by Distribution Channel
        • 7.5.5.4 Rest of LAMEA
          • 7.5.5.4.1 Key market trends, growth factors and opportunities
          • 7.5.5.4.2 Market size and forecast, by Type
          • 7.5.5.4.3 Market size and forecast, by Application
          • 7.5.5.4.4 Market size and forecast, by Distribution Channel
  • CHAPTER 8: COMPANY LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Key developments

  • CHAPTER 9: COMPANY PROFILES

    • 9.1 Aenova Group

      • 9.1.1 Company overview

      • 9.1.2 Company snapshot

      • 9.1.3 Operating business segments

      • 9.1.4 Product portfolio

      • 9.1.5 Business performance

      • 9.1.6 Key strategic moves and developments

    • 9.2 Best Formulations, Inc.

      • 9.2.1 Company overview

      • 9.2.2 Company snapshot

      • 9.2.3 Operating business segments

      • 9.2.4 Product portfolio

      • 9.2.5 Business performance

      • 9.2.6 Key strategic moves and developments

    • 9.3 Captek Softgel International, Inc.

      • 9.3.1 Company overview

      • 9.3.2 Company snapshot

      • 9.3.3 Operating business segments

      • 9.3.4 Product portfolio

      • 9.3.5 Business performance

      • 9.3.6 Key strategic moves and developments

    • 9.4 Catalant, Inc.

      • 9.4.1 Company overview

      • 9.4.2 Company snapshot

      • 9.4.3 Operating business segments

      • 9.4.4 Product portfolio

      • 9.4.5 Business performance

      • 9.4.6 Key strategic moves and developments

    • 9.5 DCC Plc. (Eurocaps)

      • 9.5.1 Company overview

      • 9.5.2 Company snapshot

      • 9.5.3 Operating business segments

      • 9.5.4 Product portfolio

      • 9.5.5 Business performance

      • 9.5.6 Key strategic moves and developments

    • 9.6 Procaps Groups

      • 9.6.1 Company overview

      • 9.6.2 Company snapshot

      • 9.6.3 Operating business segments

      • 9.6.4 Product portfolio

      • 9.6.5 Business performance

      • 9.6.6 Key strategic moves and developments

    • 9.7 Robinson Pharma, Inc.

      • 9.7.1 Company overview

      • 9.7.2 Company snapshot

      • 9.7.3 Operating business segments

      • 9.7.4 Product portfolio

      • 9.7.5 Business performance

      • 9.7.6 Key strategic moves and developments

    • 9.8 Lyfe Group (Caps Canada)

      • 9.8.1 Company overview

      • 9.8.2 Company snapshot

      • 9.8.3 Operating business segments

      • 9.8.4 Product portfolio

      • 9.8.5 Business performance

      • 9.8.6 Key strategic moves and developments

    • 9.9 Sirio Pharma Co. (Ayanda)

      • 9.9.1 Company overview

      • 9.9.2 Company snapshot

      • 9.9.3 Operating business segments

      • 9.9.4 Product portfolio

      • 9.9.5 Business performance

      • 9.9.6 Key strategic moves and developments

    • 9.10 Thermofisher Scientific, Inc (Patheon)

      • 9.10.1 Company overview

      • 9.10.2 Company snapshot

      • 9.10.3 Operating business segments

      • 9.10.4 Product portfolio

      • 9.10.5 Business performance

      • 9.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 2. SOFTGEL CAPSULE MARKET, FOR GELATIN SOFTGEL CAPSULES, BY REGION, 2021-2031 ($MILLION)
    TABLE 3. SOFTGEL CAPSULE MARKET FOR GELATIN SOFTGEL CAPSULES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 4. SOFTGEL CAPSULE MARKET, FOR NON-GELATIN SOFTGEL CAPSULES, BY REGION, 2021-2031 ($MILLION)
    TABLE 5. SOFTGEL CAPSULE MARKET FOR NON-GELATIN SOFTGEL CAPSULES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 6. GLOBAL NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET, BY MATERIAL, 2021-2031 ($MILLION)
    TABLE 7. SOFTGEL CAPSULE MARKET, FOR STARCH, BY REGION, 2021-2031 ($MILLION)
    TABLE 8. SOFTGEL CAPSULE MARKET, FOR CELLULOSE, BY REGION, 2021-2031 ($MILLION)
    TABLE 9. SOFTGEL CAPSULE MARKET, FOR PULLULAN, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. GLOBAL SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 11. SOFTGEL CAPSULE MARKET, FOR PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. SOFTGEL CAPSULE MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 13. SOFTGEL CAPSULE MARKET, FOR HEALTH SUPPLEMENTS, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. SOFTGEL CAPSULE MARKET FOR HEALTH SUPPLEMENTS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 15. SOFTGEL CAPSULE MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. SOFTGEL CAPSULE MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 17. GLOBAL SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 18. SOFTGEL CAPSULE MARKET, FOR SUPERMARKETS AND HYPERMARKETS, BY REGION, 2021-2031 ($MILLION)
    TABLE 19. SOFTGEL CAPSULE MARKET FOR SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 20. SOFTGEL CAPSULE MARKET, FOR PHARMACIES AND DRUG STORES, BY REGION, 2021-2031 ($MILLION)
    TABLE 21. SOFTGEL CAPSULE MARKET FOR PHARMACIES AND DRUG STORES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 22. SOFTGEL CAPSULE MARKET, FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 23. SOFTGEL CAPSULE MARKET FOR ONLINE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 24. SOFTGEL CAPSULE MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 25. NORTH AMERICA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 26. NORTH AMERICA NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET, BY MATERIAL, 2021-2031 ($MILLION)
    TABLE 27. NORTH AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 28. NORTH AMERICA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 29. NORTH AMERICA SOFTGEL CAPSULE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 30. U.S. SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 31. U.S. SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 32. U.S. SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 33. CANADA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 34. CANADA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 35. CANADA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 36. MEXICO SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 37. MEXICO SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 38. MEXICO SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 39. EUROPE SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 40. EUROPE NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET, BY MATERIAL, 2021-2031 ($MILLION)
    TABLE 41. EUROPE SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 42. EUROPE SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 43. EUROPE SOFTGEL CAPSULE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 44. GERMANY SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 45. GERMANY SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 46. GERMANY SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 47. FRANCE SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 48. FRANCE SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 49. FRANCE SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 50. UK SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 51. UK SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 52. UK SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 53. ITALY SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 54. ITALY SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 55. ITALY SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 56. SPAIN SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 57. SPAIN SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 58. SPAIN SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 59. REST OF EUROPE SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 60. REST OF EUROPE SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 61. REST OF EUROPE SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 62. ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 63. ASIA-PACIFIC NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET, BY MATERIAL, 2021-2031 ($MILLION)
    TABLE 64. ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 65. ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 66. ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 67. JAPAN SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 68. JAPAN SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 69. JAPAN SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 70. CHINA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 71. CHINA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 72. CHINA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 73. INDIA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 74. INDIA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 75. INDIA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 76. AUSTRALIA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 77. AUSTRALIA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 78. AUSTRALIA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 79. SOUTH KOREA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 80. SOUTH KOREA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 81. SOUTH KOREA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 82. REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 83. REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 84. REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 85. LAMEA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 86. LAMEA NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET, BY MATERIAL, 2021-2031 ($MILLION)
    TABLE 87. LAMEA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 88. LAMEA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 89. LAMEA SOFTGEL CAPSULE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 90. BRAZIL SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 91. BRAZIL SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 92. BRAZIL SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 93. SAUDI ARABIA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 94. SAUDI ARABIA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 95. SAUDI ARABIA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 96. SOUTH AFRICA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 97. SOUTH AFRICA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 98. SOUTH AFRICA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 99. REST OF LAMEA SOFTGEL CAPSULE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 100. REST OF LAMEA SOFTGEL CAPSULE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 101. REST OF LAMEA SOFTGEL CAPSULE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 102.AENOVA GROUP: COMPANY SNAPSHOT
    TABLE 103.AENOVA GROUP: OPERATING SEGMENTS
    TABLE 104.AENOVA GROUP: PRODUCT PORTFOLIO
    TABLE 105.AENOVA GROUP: NET SALES,
    TABLE 106.AENOVA GROUP: KEY STRATERGIES
    TABLE 107.BEST FORMULATIONS, INC.: COMPANY SNAPSHOT
    TABLE 108.BEST FORMULATIONS, INC.: OPERATING SEGMENTS
    TABLE 109.BEST FORMULATIONS, INC.: PRODUCT PORTFOLIO
    TABLE 110.BEST FORMULATIONS, INC.: NET SALES,
    TABLE 111.BEST FORMULATIONS, INC.: KEY STRATERGIES
    TABLE 112.CAPTEK SOFTGEL INTERNATIONAL, INC.: COMPANY SNAPSHOT
    TABLE 113.CAPTEK SOFTGEL INTERNATIONAL, INC.: OPERATING SEGMENTS
    TABLE 114.CAPTEK SOFTGEL INTERNATIONAL, INC.: PRODUCT PORTFOLIO
    TABLE 115.CAPTEK SOFTGEL INTERNATIONAL, INC.: NET SALES,
    TABLE 116.CAPTEK SOFTGEL INTERNATIONAL, INC.: KEY STRATERGIES
    TABLE 117.CATALANT, INC.: COMPANY SNAPSHOT
    TABLE 118.CATALANT, INC.: OPERATING SEGMENTS
    TABLE 119.CATALANT, INC.: PRODUCT PORTFOLIO
    TABLE 120.CATALANT, INC.: NET SALES,
    TABLE 121.CATALANT, INC.: KEY STRATERGIES
    TABLE 122.DCC PLC. (EUROCAPS): COMPANY SNAPSHOT
    TABLE 123.DCC PLC. (EUROCAPS): OPERATING SEGMENTS
    TABLE 124.DCC PLC. (EUROCAPS): PRODUCT PORTFOLIO
    TABLE 125.DCC PLC. (EUROCAPS): NET SALES,
    TABLE 126.DCC PLC. (EUROCAPS): KEY STRATERGIES
    TABLE 127.PROCAPS GROUPS: COMPANY SNAPSHOT
    TABLE 128.PROCAPS GROUPS: OPERATING SEGMENTS
    TABLE 129.PROCAPS GROUPS: PRODUCT PORTFOLIO
    TABLE 130.PROCAPS GROUPS: NET SALES,
    TABLE 131.PROCAPS GROUPS: KEY STRATERGIES
    TABLE 132.ROBINSON PHARMA, INC.: COMPANY SNAPSHOT
    TABLE 133.ROBINSON PHARMA, INC.: OPERATING SEGMENTS
    TABLE 134.ROBINSON PHARMA, INC.: PRODUCT PORTFOLIO
    TABLE 135.ROBINSON PHARMA, INC.: NET SALES,
    TABLE 136.ROBINSON PHARMA, INC.: KEY STRATERGIES
    TABLE 137.LYFE GROUP (CAPS CANADA): COMPANY SNAPSHOT
    TABLE 138.LYFE GROUP (CAPS CANADA): OPERATING SEGMENTS
    TABLE 139.LYFE GROUP (CAPS CANADA): PRODUCT PORTFOLIO
    TABLE 140.LYFE GROUP (CAPS CANADA): NET SALES,
    TABLE 141.LYFE GROUP (CAPS CANADA): KEY STRATERGIES
    TABLE 142.SIRIO PHARMA CO. (AYANDA): COMPANY SNAPSHOT
    TABLE 143.SIRIO PHARMA CO. (AYANDA): OPERATING SEGMENTS
    TABLE 144.SIRIO PHARMA CO. (AYANDA): PRODUCT PORTFOLIO
    TABLE 145.SIRIO PHARMA CO. (AYANDA): NET SALES,
    TABLE 146.SIRIO PHARMA CO. (AYANDA): KEY STRATERGIES
    TABLE 147.THERMOFISHER SCIENTIFIC, INC (PATHEON): COMPANY SNAPSHOT
    TABLE 148.THERMOFISHER SCIENTIFIC, INC (PATHEON): OPERATING SEGMENTS
    TABLE 149.THERMOFISHER SCIENTIFIC, INC (PATHEON): PRODUCT PORTFOLIO
    TABLE 150.THERMOFISHER SCIENTIFIC, INC (PATHEON): NET SALES,
    TABLE 151.THERMOFISHER SCIENTIFIC, INC (PATHEON): KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.SOFTGEL CAPSULE MARKET SEGMENTATION
    FIGURE 2.SOFTGEL CAPSULE MARKET,2021-2031
    FIGURE 3.SOFTGEL CAPSULE MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.SOFTGEL CAPSULE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.PATENT ANALYSIS BY COMPANY
    FIGURE 13.PATENT ANALYSIS BY COUNTRY
    FIGURE 14.SOFTGEL CAPSULE MARKET,BY TYPE,2021(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 17.SOFTGEL CAPSULE MARKET,BY APPLICATION,2021(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HEALTH SUPPLEMENTS SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF COSMETICS SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 21.SOFTGEL CAPSULE MARKET,BY DISTRIBUTION CHANNEL,2021(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SUPERMARKETS AND HYPERMARKETS SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PHARMACIES AND DRUG STORES SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PROVIDERS SOFTGEL CAPSULE MARKET,2021-2031(%)
    FIGURE 25.SOFTGEL CAPSULE MARKET BY REGION,2021
    FIGURE 26.U.S. SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 27.CANADA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 28.MEXICO SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 29.GERMANY SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 30.FRANCE SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 31.UK SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 32.ITALY SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 33.SPAIN SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 34.REST OF EUROPE SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 35.JAPAN SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 36.CHINA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 37.INDIA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 38.AUSTRALIA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 39.SOUTH KOREA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 40.REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 41.BRAZIL SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 42.SAUDI ARABIA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 43.SOUTH AFRICA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 44.REST OF LAMEA SOFTGEL CAPSULE MARKET,2021-2031($MILLION)
    FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 49.COMPETITIVE DASHBOARD
    FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 51.AENOVA GROUP.: NET SALES ,($MILLION)
    FIGURE 52.BEST FORMULATIONS, INC..: NET SALES ,($MILLION)
    FIGURE 53.CAPTEK SOFTGEL INTERNATIONAL, INC..: NET SALES ,($MILLION)
    FIGURE 54.CATALANT, INC..: NET SALES ,($MILLION)
    FIGURE 55.DCC PLC. (EUROCAPS).: NET SALES ,($MILLION)
    FIGURE 56.PROCAPS GROUPS.: NET SALES ,($MILLION)
    FIGURE 57.ROBINSON PHARMA, INC..: NET SALES ,($MILLION)
    FIGURE 58.LYFE GROUP (CAPS CANADA).: NET SALES ,($MILLION)
    FIGURE 59.SIRIO PHARMA CO. (AYANDA).: NET SALES ,($MILLION)
    FIGURE 60.THERMOFISHER SCIENTIFIC, INC (PATHEON).: NET SALES ,($MILLION)

Purchase Full Report of
Softgel Capsules Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue